Douglas E. Giordano

Insider Reports History

Entity
Individual
Location
C/O Pfizer Inc., 235 East 42 Nd Street, New York, New York
Signature
/s/ Mark Bodenrader, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Douglas E. Giordano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cerevel Therapeutics Holdings, Inc. Director Common Stock 0 $0 $41.18 Aug 1, 2024 Direct
Cerevel Therapeutics Holdings, Inc. Director Stock Option (Right to Buy) 0 Aug 1, 2024 Direct

Insider Reports Filed by Douglas E. Giordano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CERE Cerevel Therapeutics Holdings, Inc. Aug 1, 2024 3 $0 4 Aug 5, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 7, 2023 2 $0 4 Jun 9, 2023 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
CERE Cerevel Therapeutics Holdings, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director